Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002017193-24-000001
Filing Date
2024-04-03
Accepted
2024-04-03 16:06:36
Documents
1
Effectiveness Date
2024-04-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10263
  Complete submission text file 0002017193-24-000001.txt   11339
Mailing Address 3115 MERRYFIELD ROW, SUITE 210 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW, SUITE 210 SAN DIEGO CA 92121 (858) 523-5400
Mirador Therapeutics, Inc. (Filer) CIK: 0002017193 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509562 | Film No.: 24818721